Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
4D Molecular Therapeutics Inc
(NQ:
FDMT
)
15.50
-0.34 (-2.15%)
Streaming Delayed Price
Updated: 10:42 AM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about 4D Molecular Therapeutics Inc
< Previous
1
2
3
4
5
Next >
FDMT Stock Earnings: 4D Molecular Therapeutics Beats EPS for Q2 2024
August 09, 2024
FDMT stock results show that 4D Molecular Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 18, 2024
Via
Benzinga
Peeling Back The Layers: Exploring 4D Molecular Therapeutics Through Analyst Insights
July 18, 2024
Via
Benzinga
4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate
July 17, 2024
4D Molecular Therapeutics reports 24-week interim data from its PRISM Phase 2 trial, showing 77% of wet AMD patients injection-free with 4D-150. The trial highlights safety and efficacy in reducing...
Via
Benzinga
Assessing 4D Molecular Therapeutics: Insights From 7 Financial Analysts
June 26, 2024
Via
Benzinga
Analyst Expectations For 4D Molecular Therapeutics's Future
June 07, 2024
Via
Benzinga
4D Molecular Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
March 01, 2024
Via
Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
Via
Benzinga
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
June 07, 2024
Goldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.
Via
Benzinga
Why Is 4D Molecular Therapeutics Stock Trading Lower On Thursday? Genetic Disease-Focused Study Data Released
June 06, 2024
4D Molecular Therapeutics shares interim data from the 4D-710 Phase 1/2 AEROW clinical trial for cystic fibrosis lung disease.
Via
Benzinga
What 4 Analyst Ratings Have To Say About 4D Molecular Therapeutics
February 07, 2024
Via
Benzinga
Why Is 4D Molecular (FDMT) Stock Up 85% Today?
February 05, 2024
Investors in 4D Molecular Therapeutics and FDMT stock are seeing big gains today, as the stock surges 80% on positive trial results.
Via
InvestorPlace
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 06, 2024
Via
Benzinga
FDMT Stock Earnings: 4D Molecular Therapeutics Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
FDMT stock results show that 4D Molecular Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
April 18, 2024
Via
Benzinga
Topics
ETFs
4D Molecular Therapeutics Outlines Pivotal Development Plans For Cystic Fibrosis, Rare Inherited Disease
March 28, 2024
4D Molecular Therapeutics' latest advancements in CF treatment. Get insights into their 4D-710 aerosolized genetic medicine for cystic fibrosis lung disease, including Phase 1/2 AEROW trial updates and...
Via
Benzinga
Why Is Blindness Focused-Adverum Biotechnologies Stock Trading Lower Today?
February 08, 2024
Adverum Biotechnologies' Ixo-vec gene therapy for wet AMD. Preliminary LUNA Phase 2 trial data show safety, efficacy, and significant treatment burden reduction.
Via
Benzinga
Why 4D Molecular Therapeutics (FDMT) Stock Is Diving
February 07, 2024
4D Molecular Therapeutics shares are trading lower by 12.7% Wednesday afternoon. The company announced pricing of an upsized underwritten public offering.
Via
Benzinga
4D Molecular Therapeutics' 4D-150 Phase 2 Data Met Investor Expectations, Analyst Boosts Forecast
February 06, 2024
4D Molecular Therapeutics' 4D-150 Phase 2 results for wet AMD treatment. BMO Capital optimistic, target price raised to $70.
Via
Benzinga
Crude Oil Moves Higher; Caterpillar Posts Upbeat Earnings
February 05, 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 200 points on Monday. The Dow traded down 0.53% to 38,450.28 while the NASDAQ fell 0.11% to 15,612.52. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 05, 2024
Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 05, 2024
Via
Benzinga
Gold Moves Lower; ISM Services PMI Beats Estimates
February 05, 2024
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Monday. The Dow traded down 1.04% to 38,253.72 while the NASDAQ fell 0.86% to 15,493.97. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Eye Disease-Focused 4D Molecular Therapeutics Stock Shooting Higher Today?
February 05, 2024
4D Molecular Therapeutics data in wet AMD treatment. Phase 2 PRISM trial shows promising results - 89% reduction in anti-VEGF injections, stable visual acuity.
Via
Benzinga
Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday
February 05, 2024
U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Tumbles 150 Points; McDonald's Sales Miss Views
February 05, 2024
U.S. stocks traded lower this morning, with the Dow Jones index falling around 150 points on Monday. Following the market opening Monday, the Dow traded down 0.41% to 38,494.03 while the NASDAQ fell...
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 05, 2024
Via
Benzinga
Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
February 05, 2024
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 05, 2024
The biggest pre-market stock movers are starting off the trading week as we check out all of the hottest news for Monday morning!
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.